Objective:

To discuss the decision-making process for offering collagen corneal cross-linking (CXL) and rigid contact lenses to patients with moderate to advanced progressive keratoconus.

Key Findings:

• CXL and scleral lenses are both necessary for managing progressive keratoconus.
• Individualized decision-making is crucial based on patient circumstances.
• Insurance requirements can affect the timing of CXL and lens fitting.

Interpretation:

The timing of CXL and lens fitting should be tailored to each patient's unique situation, considering factors like vision impairment, insurance, and financial constraints.

Limitations:

• Insurance policies may complicate the authorization process for CXL.
• Lack of baseline data in new patients can delay CXL.

Conclusion:

Both CXL and scleral lenses are essential components in treating progressive keratoconus, and careful consideration of patient-specific factors can optimize treatment outcomes.